SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Meghmani Finechem informs about BRSR

03 Jun 2023 Evaluate

Pursuant to Regulation 34 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Meghmani Finechem has informed that it enclosed the Business Responsibility and Sustainability Report (BRSR) for the FY2022-23, which forms an integral part of the Annual Report for the FY2022-23. The Annual Report for the FY2022-23 is also available on Company's website at www.meghmanifinechem.com.

The above information is a part of company’s filings submitted to BSE.

Epigral Share Price

1350.05 -11.05 (-0.81%)
07-May-2026 09:47 View Price Chart
Peers
Company Name CMP
BASF India 3858.95
Tata Chemicals 817.65
SRF 2719.65
Pidilite Inds. 1440.25
Deepak Nitrite 1832.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×